Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.
about
HPV & head and neck cancer: a descriptive updateConcurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinomaConcurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinomaSquamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationRecent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerSalvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and reviewSupratracheal laryngectomy: current indications and contraindications.Role of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinomaThe role of systemic treatment before, during, and after definitive treatmentCurrent role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinomaAn updated overview of HPV-associated head and neck carcinomasRandomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.The Indian scenario of head and neck oncology - Challenging the dogmasAn update on larynx cancerIdentification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavityTomotherapy: implications on daily workload and scheduling patients based on three years' institutional experienceCollagen gel droplet-embedded culture drug sensitivity testing in squamous cell carcinoma cell lines derived from human oral cancers: Optimal contact concentrations of cisplatin and fluorouracilModified epidermal growth factor receptor (EGFR)-bearing liposomes (MRBLs) are sensitive to EGF in solutionKaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cellsTrans-oral partial epiglottidectomy to treat dysphagia in post-treatment head and neck cancer patients: a preliminary reportGuidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.Otolaryngology-head and neck surgery at Johns Hopkins: The first 100 years (1914-2014)The role of neck dissection in squamous cell carcinoma of the head and neck.Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.Phototheranostic Porphyrin Nanoparticles Enable Visualization and Targeted Treatment of Head and Neck Cancer in Clinically Relevant Models.Up-front and Salvage Transoral Robotic Surgery for Head and Neck Cancer: A Belgian Multicenter Retrospective Case SeriesMonitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imagingPreservation of organ function in head and neck cancer.Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in vitro and in vivo.Functional organ preservation in laryngeal and hypopharyngeal cancer.Effects of chemoradiotherapy on voice and swallowingA genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival.Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements.Role of surgery in the management of head and neck cancer: a contemporary view of the data in the era of organ preservation.Survival outcome depending on different treatment strategies in advanced stages III and IV laryngeal cancers: an audit of data from two European centres.Evidence-based review of treatment options for patients with glottic cancer.Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.Transoral robotic total laryngectomy.Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer.
P2860
Q21198763-EDEC0964-682F-4268-AAAC-6DEF565EC7DDQ24186289-8F090915-A368-4AE6-9A81-8D5EE420C50EQ24201507-C0D165A6-13F8-4C31-B3B4-54CC1FDD8DC6Q26765060-8D07C5D5-2F8C-425F-BC95-292F1AD03422Q26782255-1ED8E7A0-57C8-4EEA-87B6-3F64BC502E89Q26798275-5F2952AA-4CD4-45CA-867F-B3925D00B436Q26798282-B4490DCD-9F94-4F1B-91AF-92734356B325Q26825536-883CB250-1642-4D30-9BF1-77A04D0AE927Q26859285-80D37BE6-E0B5-47CE-8FD0-257BA678E585Q26991953-709D3249-20DB-4258-BA68-8F0F12A7E07AQ27014019-436F2BAE-9231-4BC7-8D17-8D800A6A20EDQ27313572-C0952DF1-F8B1-45CC-8C80-288DEB989ACDQ28072546-4E5706EA-5EEF-435F-863F-FC961E04ABFBQ28079132-A9248025-5033-4E34-A3FC-32A3ADEC08CFQ28273903-DF5365B2-6772-4665-B0C8-4DBD61AD06A4Q28299245-954F4F2A-7ECD-44B7-B019-EC83FD66B7CDQ28468348-C5DA6A58-ED0F-4607-B492-9F8675C3477EQ28476290-B8FEA0C4-90F3-4706-AB59-D2141C2A4562Q28535291-0DE1234E-8C45-47C4-BF0B-8F43EFEBE0C5Q28972435-F342FBFA-37AF-405F-A9CA-CF3F572FF352Q30361804-348A7608-0273-43B3-89DA-07DD745591B4Q30361906-1628CFBB-2958-4E45-8B96-4F84F9AC5119Q30366869-014F069D-B959-4C0C-9E45-1DB8BB6B9680Q30373904-C958F4B7-5A2A-4622-A509-CF61BCEAD27BQ30395878-3E9CFA1A-3D87-40D7-A82E-FDE987E2D50BQ30399047-CCF6991D-9850-4959-B7A8-4CB811F2E4CFQ30452632-72DEFA6B-0CDF-4D93-BB10-2F9460F80256Q30459136-093B73B3-D0E4-4488-9455-8C485735648EQ30464657-83FDB25A-117D-4DE7-B710-ABDFFB5D0C24Q30467853-C3AD76FF-4218-4D07-B65E-CB2601DCC6E2Q30481224-45F0C8C3-E3B3-40B2-8024-D71729BDDB99Q30487675-4638ED0B-EEB1-464A-A2F9-F9CA681C2104Q30539275-9CD1ADD9-3432-4761-9EA5-5C6920FE3310Q30585078-C604CDE7-E741-4973-B051-5456E136FEFFQ30664501-2D47AD54-2CE5-43B3-A77D-D1E38E0E4FF6Q31032091-46162756-39BF-4340-A50D-476317C99748Q31063952-D99396DD-170D-4611-A5AF-C6D6B38F054EQ31110768-D2A28842-4153-45AE-9F47-B4F8DF5A8463Q31160694-41375BF2-AC8F-490A-8D9C-3CA6FFA4719DQ33331068-A1C59397-F585-4CAC-A9E2-14259F3F4FD7
P2860
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Concurrent chemotherapy and ra ...... in advanced laryngeal cancer.
@en
Concurrent chemotherapy and ra ...... in advanced laryngeal cancer.
@nl
type
label
Concurrent chemotherapy and ra ...... in advanced laryngeal cancer.
@en
Concurrent chemotherapy and ra ...... in advanced laryngeal cancer.
@nl
prefLabel
Concurrent chemotherapy and ra ...... in advanced laryngeal cancer.
@en
Concurrent chemotherapy and ra ...... in advanced laryngeal cancer.
@nl
P2093
P921
P356
P1476
Concurrent chemotherapy and ra ...... in advanced laryngeal cancer.
@en
P2093
Andrea Leaf
Andy Trotti
Arlene A Forastiere
Bonnie Glisson
Clifford Chao
Ding-Jen Lee
Glen Peters
Helmuth Goepfert
Jay Cooper
John A Ridge
P304
P356
10.1056/NEJMOA031317
P407
P577
2003-11-01T00:00:00Z